Clinical Trials Logo

ErbB Receptors clinical trials

View clinical trials related to ErbB Receptors.

Filter by:
  • None
  • Page 1

NCT ID: NCT02695290 Terminated - Clinical trials for Carcinoma, Non-Small-Cell Lung

Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)

Start date: March 17, 2016
Phase: Phase 4
Study type: Interventional

There is a medical need for improving treatment of poor performance status patients with EGFR driver mutations and documenting safety and tolerability of existing agents.

NCT ID: NCT02514174 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Start date: August 18, 2015
Phase: Phase 4
Study type: Interventional

Continuous treatment until progression or occurence of intolerable Adverse Event (AE) or end of trial. The end of trial is one year after the last patient has entered the study.